BI
APTO

BVF Inc’s Aptose Biosciences, Inc. APTO Stock Holding History

BVF Inc’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-92
Closed -$179K – 31
2015
Q3 		$179K Sell
92
-142
-61% -$316K 0.04% 27
2015
Q2 		$538K Sell
234
-136
-37% -$356K 0.1% 30
2015
Q1 		$907K Hold
370
– – 0.19% 27
2014
Q4 		$986K Buy
+370
New +$1.11M 0.19% 28

Other funds holding APTO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

BVF Inc's APTO Position: Q4 2015 in Review

BVF Inc sold out of Aptose Biosciences, Inc. (APTO) in Q4 2015, closing a stake of 92 shares — an estimated $179K sold.

BVF Inc first reported a position in APTO in Q4 2014 and held it in 4 quarters. The position peaked at $986K in Q4 2014. 11 funds tracked by Wall St. Rank hold APTO as of Q4 2015.

  • BVF Inc reported no remaining Aptose Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • BVF Inc sold 92 Aptose Biosciences, Inc. shares in Q4 2015, an estimated $179K.
  • BVF Inc first reported a position in Aptose Biosciences, Inc. in Q4 2014 and held it in 4 quarters.
  • BVF Inc's Aptose Biosciences, Inc. position peaked at $986K in Q4 2014.
  • 11 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2015.

Based on BVF Inc's 13F filing for Q4 2015, filed 16 Feb 2016.